Background Few studies have evaluated access to and retention in pre-ART care. Objectives To evaluate the proportion of People Living With HIV (PLWH) in pre-ART and ART care and factors associated with retention in pre-ART and ART care from a community cohort. Methods A cross sectional survey was conducted from February – April 2011. Self reported HIV positive, negative or participants of unknown status completed a questionnaire on their HIV testing history, access to pre-ART and retention in pre-ART and ART care. Results 872 randomly selected adults who reported being HIV positive in the ZAMSTAR 2010 prevalence survey were included and revisited. 579 (66%) reconfirmed their positive status and were included in this analysis. 380 (66%) had initiated ART with 357 of these (94%) retained in ART care. 199 (34%) had never initiated ART of whom 186 (93%) accessed pre-ART care, and 86 (43%) were retained in pre-ART care. In a univariable analysis none of the factors analysed were significantly associated with retention in care in the pre-ART group. Due to the high retention in ART care, factors associated with retention in ART care, were not analysed further. Conclusion Retention in ART care was high; however it was low in pre-ART care. The opportunity exists, if care is better integrated, to engage with clients in primary health care facilities to bring them back to, and retain them in, pre-ART care.
References
[1]
South African National Department of Health (2013) National Strategic Plan on HIV, STIs and TB 2012–2016. Pretoria.
[2]
UNAIDS (n.d.) South Africa UNAIDS Fact Sheet. Available: http://www.unaids.org/en/regionscountrie？s/countries/southafrica/.
[3]
Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: : 1897–1908. Available: http://www.ncbi.nlm.nih.gov/pubmed/18784？453. Accessed 2 Sept 2013.
[4]
Jarvis JN, Meintjes G, Wood R, Harrison TS (2010) Testing but not treating: missed opportunities and lost lives in the South African ART programme. AIDS 24: 1233–1235 doi:10.1097/QAD.0b013e3283383aeb.Testing.
[5]
The IeDEA and ART cohort collaborations (2014) Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries. J Acquir Immune Defic Syndr 65: 8–16.
[6]
Ingle SM, May M, Uebel K, Timmerman V, Kotze E, et al. (2010) Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: A prospective cohort study. S Afr Med J 100: 675–681 Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=3059232&tool=pmcentrez？&rendertype=abstract.
[7]
South African National Department of Health (2010) South African National Department of Health. Clinical Guidelines for the management of HIV & AIDS in Adults and Adolescents. Pretoria.
[8]
Rosen S, Fox MP (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: : e1001056. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=3139665&tool=pmcentrez？&rendertype=abstract. Accessed 27 May 2013.
[9]
Scott V, Zweigenthal V, Jennings K (2011) Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa. Trop Med Int Health 16: : 1384–1391. Available: http://www.ncbi.nlm.nih.gov/pubmed/21771？213. Accessed 8 Jul 2013.
[10]
Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, et al.. (2010) Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One 5: : e13801. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=2970551&tool=pmcentrez？&rendertype=abstract. Accessed 23 Aug 2013.
[11]
Losina E, Bassett I V, Giddy J, Chetty S, Regan S, et al.. (2010) The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One 5: : e9538. Available: http://dx.plos.org/10.1371/journal.pone.？0009538. Accessed 23 May 2013.
[12]
Lessells RJ, Mutevedzi PC, Cooke GS (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 56: 1–16 doi:10.1097/QAI.0b013e3182075ae2.Retention.
[13]
Larson B a, Brennan A, McNamara L, Long L, Rosen S, et al.. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 Suppl 1: 43–47. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=2954490&tool=pmcentrez？&rendertype=abstract. Accessed 23 Aug 2013.
[14]
South African National Department of Health (2013) The South African Antiretroviral Treatment Guidelines. Pretoria.
[15]
Ayles HM, Sismanidis C, Beyers N, Hayes RJ, Godfrey-Faussett P (2008) ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2×2 factorial community randomized trial. Trials 9: : 63. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=2585552&tool=pmcentrez？&rendertype=abstract. Accessed 8 Nov 2013.
[16]
Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, et al. (1AD) Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. The Lancet. Available: http://linkinghub.elsevier.com/retrieve/？pii/S0140673613611319.
[17]
Actuarial Society of South Africa (2011) ASSA 2008 AIDS and Demographic Model. Available: http://aids.actuarialsociety.org.za. Accessed 8 December 2011.
[18]
Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, et al.. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18: : 887–895. Available: http://www.ncbi.nlm.nih.gov/pubmed/15060？436. Accessed 15 Nov2013.
[19]
Ford N, Reuter H, Bedelu M, Schneider H, Reuter H (2006) Sustainability of Long-Term treatment in a rural district: the Lusikisiki model of decentralised HIV/AIDS care. South African J HIV Med: 17–21.
[20]
Marston BJ, Macharia DK, Nga'nga L, Wangai M, Ilako F, et al.. (2007) A program to provide antiretroviral therapy to residents of an urban slum in nairobi, kenya. J Int Assoc Physicians AIDS Care (Chic) 6: : 106–112. Available: http://www.ncbi.nlm.nih.gov/pubmed/17538？002. Accessed 15 Nov 2013.
[21]
Brinkhof MW, Dabis F, Myer LBangsberg DR BA (n.d.) WHO | Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. Available: http://www.who.int/bulletin/volumes/86/7？/07-044248/en/. Accessed 15 Nov 2013.
[22]
Loveday M, Zweigenthal V (2011) TB and HIV integration: obstacles and possible solutions to implementation in South Africa. Trop Med Int Health. 16: : 431–438 Available: http://www.ncbi.nlm.nih.gov/pubmed/21255？204. Accessed 21 May 2013.
[23]
Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, et al.. (2011) Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One 6: : e19484. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=3093394&tool=pmcentrez？&rendertype=abstract. Accessed 3 Sept 2013.
[24]
Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al.. (2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9: : 290. Available: http://www.pubmedcentral.nih.gov/article？render.fcgi?artid=2734853&tool=pmcentrez？&rendertype=abstract. Accessed 11 Mar 2014.
[25]
Fried J, Harris B, Eyles J (2012) Hopes interrupted: accessing and experiences of antiretroviral therapy in South Africa. Sex Transm Infect 88: : 147–151. Available: http://www.ncbi.nlm.nih.gov/pubmed/22345？030. Accessed 1 Apr 2014.
